We are live on ! Find out more
SC

Syon Capital Portfolio holdings

AUM $2.3B
1-Year Est. Return 25.92%
This Fund
S&P 500
This Quarter Est. Return
+14.83%
1 Year Est. Return
+25.92%
3 Year Est. Return
+74.02%
5 Year Est. Return
10 Year Est. Return
AUM
$2.3B
AUM Growth
+$307M
Cap. Flow
+$120M
Cap. Flow %
5.21%
Top 10 Hldgs %
25.88%
Holding
1,020
New
114
Increased
517
Reduced
305
Closed
70

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.58%
2 Technology 19.13%
3 Communication Services 10.14%
4 Financials 8.67%
5 Consumer Discretionary 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
926
Vodafone
VOD
$39.3B
$188K 0.01%
14,180
-699
-5% -$10.6K
PBI icon
927
Pitney Bowes
PBI
$2.33B
$187K 0.01%
10,658
-693
-6% -$10.6K
AES icon
928
AES
AES
$10.6B
$179K 0.01%
+12,221
New +$178K
GNL icon
929
Global Net Lease
GNL
$2.03B
$167K 0.01%
18,725
-5,510
-23% -$51.5K
PRGO icon
930
Perrigo
PRGO
$1.85B
$160K 0.01%
+15,447
New +$170K
QNST icon
931
QuinStreet
QNST
$1.01B
$158K 0.01%
10,784
-1,728
-14% -$21.7K
NOK icon
932
Nokia
NOK
$59.6B
$156K 0.01%
11,730
+1,321
+13% +$17K
CX icon
933
Cemex
CX
$14.5B
$153K 0.01%
12,750
-1,478
-10% -$18.4K
CERT icon
934
Certara
CERT
$1.27B
$149K 0.01%
22,674
+832
+4% +$4.69K
CXM icon
935
Sprinklr
CXM
$1.24B
$131K 0.01%
+25,472
New +$135K
MYGN icon
936
Myriad Genetics
MYGN
$385M
$128K 0.01%
+22,346
New +$101K
VNDA icon
937
Vanda Pharmaceuticals
VNDA
$307M
$125K 0.01%
+20,401
New +$133K
RXRX icon
938
Recursion Pharmaceuticals
RXRX
$1.98B
$123K 0.01%
33,399
+22,429
+204% +$74.7K
CFFN icon
939
Capitol Federal Financial
CFFN
$1.09B
$103K ﹤0.01%
12,159
-8,109
-40% -$63.4K
PSKY
940
Paramount Skydance Corp
PSKY
$11.6B
$103K ﹤0.01%
+10,400
New +$109K
WEN icon
941
Wendy's
WEN
$1.29B
$100K ﹤0.01%
12,071
-12,885
-52% -$92.1K
ITUB icon
942
Itaú Unibanco
ITUB
$90.6B
$91.4K ﹤0.01%
11,182
+908
+9% +$7.53K
PGEN icon
943
Precigen
PGEN
$2.79B
$86.1K ﹤0.01%
+15,102
New +$65.3K
SPRY icon
944
ARS Pharmaceuticals
SPRY
$415M
$80.4K ﹤0.01%
+10,040
New +$86.4K
SANA icon
945
Sana Biotechnology
SANA
$919M
$64.6K ﹤0.01%
18,501
+1,838
+11% +$5.92K
IOVA icon
946
Iovance Biotherapeutics
IOVA
$4.57B
$54.1K ﹤0.01%
+13,003
New +$49.4K
ALT icon
947
Altimmune
ALT
$622M
$52K ﹤0.01%
+17,118
New +$51.1K
MDXG icon
948
MiMedx Group
MDXG
$695M
$45.1K ﹤0.01%
+11,707
New +$42.7K
PRME icon
949
Prime Medicine
PRME
$566M
$40.9K ﹤0.01%
+11,077
New +$36.8K
PLUG icon
950
Plug Power
PLUG
$2.86B
$35.2K ﹤0.01%
12,980

Similar funds

Syon Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Syon Capital held 1,020 positions worth $2.3B, up 15% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Syon Capital deployed $120M of net new capital in Q2 2026, opening 114 new positions and adding to 517 existing holdings. Its largest new stake was Powerlaw Corp: 446,818 shares worth $6.56M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $5.81M trimmed.

  • Syon Capital's largest Q2 2026 buy was Powerlaw Corp: 446,818 shares worth $6.56M.
  • Syon Capital added most to Fidelity Wise Origin Bitcoin Fund in Q2 2026, an estimated $17.4M increase.
  • Syon Capital's biggest Q2 2026 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $5.81M.
  • Syon Capital fully exited VanEck Bitcoin Trust in Q2 2026, selling an estimated $14M.
  • Syon Capital's ten largest holdings make up 26% of its $2.3B portfolio in Q2 2026.
  • Syon Capital opened 114 new positions and closed 70 in Q2 2026.
  • Syon Capital's portfolio value rose 15% quarter-over-quarter to $2.3B.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.